Main menu

The Ensembl COVID-19 resource: Ongoing integration of public SARS-CoV-2 data


The Ensembl COVID-19 browser (covid-19.ensembl.org) was launched in May 2020 in response to the ongoing pandemic. It is Ensembl’s contribution to the global efforts to develop treatments, diagnostics and vaccines for COVID-19, and it supports research into the genomic epidemiology and evolution of the SARS-CoV-2 virus. This freely available resource incorporates a new Ensembl gene set, multiple sets of variants, and alignments of annotation from several resources against the reference assembly for SARS-CoV-2.

It represents the first virus to be encompassed within the Ensembl platform. Additional data are being continually integrated via our new rapid release protocols alongside tools such as the Ensembl Variant Effect Predictor. Here we describe the data and infrastructure behind the resource and discuss future work.

Authors: Nishadi H. De Silva, Jyothish Bhai, Marc Chakiachvili, Bruno Contreras-Moreira, Carla Cummins, Adam Frankish, Astrid Gall, Thiago Genez, Kevin L. Howe, Sarah E. Hunt, Fergal J. Martin, Benjamin Moore, Denye Ogeh, Anne Parker, Andrew Parton, Magali Ruffier, Manoj Pandian Sakthivel, Dan Sheppard, John Tate, Anja Thormann, David Thybert, Stephen J. Trevanion, Andrea Winterbottom, Daniel R. Zerbino, Robert D. Finn, Paul Flicek, Andrew D. Yates

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag